The IPO Buzz: Beta Bionics Prices Upsized Deal at $17 – High End; Stock Pops on NASDAQ
Insulin delivery device maker Beta Bionics (BBNX) increased its IPO’s size to 12.0 million shares – up from 10.0 million shares – and priced the IPO at $17.00 – the top of its range – to raise $204.0 million on Wednesday night, Jan. 29, 2025. At pricing, Beta Bionics had a market cap of $729.13 million. (This column, […]
January 30, 2025 Read More